MedPath

Quinidine Gluconate

QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS USP

Approved
Approval ID

4fb02ad7-6e93-4aff-9aca-5162559b99a5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 6, 2019

Manufacturers
FDA

Richmond Pharmaceuticals, Inc.

DUNS: 043569607

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Quinidine Gluconate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54738-901
Application NumberANDA089338
Product Classification
M
Marketing Category
C73584
G
Generic Name
Quinidine Gluconate
Product Specifications
Route of AdministrationORAL
Effective DateMarch 6, 2019
FDA Product Classification

INGREDIENTS (8)

starch, cornInactive
Code: O8232NY3SJ
Classification: IACT
Quinidine GluconateActive
Quantity: 324 mg in 1 1
Code: R6875N380F
Classification: ACTIB
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
hypromellose 2208 (15000 mpa.s)Inactive
Code: Z78RG6M2N2
Classification: IACT
silicon dioxideInactive
Code: ETJ7Z6XBU4
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
sodium alginateInactive
Code: C269C4G2ZQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Quinidine Gluconate - FDA Drug Approval Details